Related Experiment Videos

Risk of ketosis during intensive insulin therapy in pre-school-age diabetic children

Diabetes Care
|January 1, 1987
PubMed

Insights

Continuous subcutaneous insulin infusion improved blood glucose control in young diabetic children. Insulin pump therapy did not increase ketosis risk, but vigilant monitoring is crucial due to potential device failures and rapid ketosis development.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Diabetes Management

Background:

  • Type 1 diabetes in pre-school-age children presents unique management challenges.
  • Intensified diabetes therapy aims for stable blood glucose control in young children.
  • Conventional insulin therapy showed limited efficacy in this cohort.

Purpose of the Study:

  • To evaluate the risk of ketosis with different insulin therapy modes in young diabetic children.
  • To assess the impact of continuous subcutaneous insulin infusion (CSII) versus conventional therapy on ketosis.
  • To determine the safety and efficacy of insulin pump therapy in pre-school-aged diabetic children.

Main Methods:

  • A subset of five pre-school-age diabetic children with poor initial response underwent intensified therapy.
  • Optimized conventional insulin therapy was used for 16 months.
  • Treatment was switched to continuous subcutaneous insulin infusion (insulin pump therapy).
  • Metabolic changes were monitored, including blood glucose, ketonuria, and diabetic ketoacidosis (DKA).
  • In-hospital cessation of insulin therapy was performed to assess metabolic response.

Main Results:

  • Conventional therapy failed to significantly improve blood glucose control and was associated with frequent ketonuria and DKA episodes.
  • Continuous subcutaneous insulin infusion rapidly improved blood glucose control without increasing ketosis or DKA frequency.
  • Most ketosis events occurred early in insulin pump therapy.
  • Deliberate insulin cessation under supervision induced similar metabolic changes (increased blood glucose, elevated 3-hydroxybutyrate, ketonuria) in both therapy groups.
  • Insulin pump therapy was not associated with increased ketosis frequency or accelerated development.

Conclusions:

  • Continuous subcutaneous insulin infusion is a safe and effective intensified therapy for young diabetic children, improving glycemic control.
  • Insulin pump therapy does not increase the risk of ketosis in this age group.
  • Parents require education on vigilance for potential device failures and prompt recognition of ketosis, emphasizing regular urine ketone testing and insulin supplementation.

Related Concept Videos